Pharmaceutical Policy Flashcards

1
Q

why should Phc care about pharmaceutical policy?

A
  1. medication experts
  2. Understanding decisions & coverage to help patients understand as well
  3. Can get involved in drug reviews to help make decisions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

who is responsible for international trade agreements with medications?

A

federal government

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

who provides the notice of complicance (NOC) for new drugs?

A

federal government (Health Canada)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when the federal government approves a new med for the market, what are the 3 key things it is looking for in the medication?

A
  1. safe
  2. effective
  3. quality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

who negotiates the prices of patented medications?

A

PMPRB (patented medicines prices review board) through the federal government

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the PMPRB (Patented Medicines Prices Review Board)?

A

a quasi-judicial branch of the federal government that protects Canadians against “excessive pricing”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are patented medications?

A

those which are still protected by law from generic duplication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

the federal government has been involved in what aspects of COVID-related initiatives?

A
  1. vaccine procurement
  2. recommendations (NACI)
  3. pharmaceuticals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is an example of a Pan-Canadian Initiative?

A

Health technology Assessments (HTA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are Health Technology Assessments?

A

independent reviews to help guide what products become funded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are 2 examples of health technology assessments?

A
  1. common drug review

2. Pan-Canadian Oncology Review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what agency runs both the common drug review and Pan-Canadian Oncology Review?

A

CADTH (Canadian Agency for Drugs and Technology in Health)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the Pan-Canadian Pharmaceutical Alliance (pCPA)?

A

a public drug program working to get Canadians better value for drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

t/f the Atlantic Common Drug Review is an example of a Pan-Canadian Initiative

A

t

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what level of government is responsible for how pharmacies are reimbursed?

A

provincial/juridicial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is assessed by the health technology assessment of a new drug?

A

clinical effectiveness & cost-effectiveness

17
Q

what is the name of the HTA agency in Quebec?

A

INESSS

18
Q

what regulatory body is able to withdraw authorization for a drug to be sold in Canada?

A

Health Canada (federal government)

19
Q

what are some challenges of expert review (HTA)?

A
  1. limited evidence, shot trials, lack of comparison to current practice
  2. uncertainty about cost-effectiveness, benefit and utility
  3. drugs keep getting more specialized and more expensive
20
Q

what are the 3 types of recommendations an HTA might make WRT funding the cost of new medications?

A
  1. Cover
  2. cover with conditions/criteria
  3. do not reimburse
21
Q

the price negotiations made by the Pan-Canadian Pharmaceutical Alliance are directed through the _____

A

Council of the Federation (Canada’s Premiers)

22
Q

what are the objectives of the Pan-Canadian Pharmaceutical Alliance?

A
  1. more access to drugs
  2. consistent drug access & cost across provinces
  3. combined “buying power”
23
Q

t/f when it comes to how new drugs are covered, each province makes their own final call

A

t

24
Q

according to the PMPRB, less than __% of Canadian population accounts for 42% of patented medicine sales

A

1%